Kaifi J, Joshi K, Suvilesh K, Natesh N, Manjunath Y, Coberly J
Res Sq. 2025; .
PMID: 39975891
PMC: 11838710.
DOI: 10.21203/rs.3.rs-5054204/v1.
Joshi K, Suvilesh K, Natesh N, Manjunath Y, Coberly J, Schlink S
bioRxiv. 2024; .
PMID: 39569144
PMC: 11577786.
DOI: 10.1101/2024.11.04.621940.
Heindel D, Figueroa Acosta D, Goff M, Yengo C, Jan M, Liu X
iScience. 2024; 27(8):110390.
PMID: 39108723
PMC: 11301080.
DOI: 10.1016/j.isci.2024.110390.
Giommetti A, Papanikolaou E
Cells. 2024; 13(12.
PMID: 38920667
PMC: 11201829.
DOI: 10.3390/cells13121039.
Stricker P, Oliveira N, Mogharbel B, Luhrs L, Irioda A, Abdelwahid E
Curr Stem Cell Res Ther. 2024; 19(7):1009-1020.
PMID: 38221663
DOI: 10.2174/011574888X268464231016070900.
Chimeric antigen receptor engineered natural killer cells for cancer therapy.
Zhang Y, Zhou W, Yang J, Yang J, Wang W
Exp Hematol Oncol. 2023; 12(1):70.
PMID: 37563648
PMC: 10413722.
DOI: 10.1186/s40164-023-00431-0.
Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells.
Hojjatipour T, Sharifzadeh Z, Maali A, Azad M
Hum Cell. 2023; 36(6):1843-1864.
PMID: 37477869
DOI: 10.1007/s13577-023-00948-w.
Lung-Targeted Transgene Expression of Nanocomplexed Ad5 Enhances Immune Response in the Presence of Preexisting Immunity.
Yang Y, Wu S, Wang Y, Shao F, Lv P, Li R
Engineering (Beijing). 2023; .
PMID: 36714358
PMC: 9869631.
DOI: 10.1016/j.eng.2022.12.007.
DEAE-Dextran Enhances the Lentiviral Transduction of Primary Human Mesenchymal Stromal Cells from All Major Tissue Sources Without Affecting Their Proliferation and Phenotype.
Amadeo F, Hanson V, Murray P, Taylor A
Mol Biotechnol. 2022; 65(4):544-555.
PMID: 35999479
PMC: 9974715.
DOI: 10.1007/s12033-022-00549-2.
Identification of a βCD-Based Hyper-Branched Negatively Charged Polymer as HSV-2 and RSV Inhibitor.
Francese R, Cecone C, Costantino M, Hoti G, Bracco P, Lembo D
Int J Mol Sci. 2022; 23(15).
PMID: 35955832
PMC: 9369026.
DOI: 10.3390/ijms23158701.
Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy.
Schmidt D, Ebrahimabadi S, Gomes K, de Moura Aguiar G, Tirapelle M, Silvestre R
Immunother Adv. 2022; 2(1):ltac003.
PMID: 35919494
PMC: 9327111.
DOI: 10.1093/immadv/ltac003.
Improving Lentiviral Transduction of Human Adipose-Derived Mesenchymal Stem Cells.
Collon K, Gallo M, Bell J, Chang S, Rodman J, Sugiyama O
Hum Gene Ther. 2022; 33(23-24):1260-1268.
PMID: 35859364
PMC: 9808795.
DOI: 10.1089/hum.2022.117.
Genetic Engineering and Enrichment of Human NK Cells for CAR-Enhanced Immunotherapy of Hematological Malignancies.
Soldierer M, Bister A, Haist C, Thivakaran A, Cengiz S, Sendker S
Front Immunol. 2022; 13:847008.
PMID: 35464442
PMC: 9022481.
DOI: 10.3389/fimmu.2022.847008.
Viral Aggregation: The Knowns and Unknowns.
Pradhan S, Varsani A, Leff C, Swanson C, Hariadi R
Viruses. 2022; 14(2).
PMID: 35216031
PMC: 8879382.
DOI: 10.3390/v14020438.
A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma.
Campos-Silva C, Caceres-Martell Y, Sanchez-Herrero E, Sandua A, Beneitez-Martinez A, Gonzalez A
J Nanobiotechnology. 2022; 20(1):72.
PMID: 35135541
PMC: 8822649.
DOI: 10.1186/s12951-022-01256-5.
Breaking Entry-and Species Barriers: LentiBOOST Plus Polybrene Enhances Transduction Efficacy of Dendritic Cells and Monocytes by Adenovirus 5.
Strack A, Deinzer A, Thirion C, Schrodel S, Dorrie J, Sauerer T
Viruses. 2022; 14(1).
PMID: 35062296
PMC: 8781300.
DOI: 10.3390/v14010092.
Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
Gong Y, Klein Wolterink R, Wang J, Bos G, Germeraad W
J Hematol Oncol. 2021; 14(1):73.
PMID: 33933160
PMC: 8088725.
DOI: 10.1186/s13045-021-01083-5.
Modifying Cell Membranes with Anionic Polymer Amphiphiles Potentiates Intracellular Delivery of Cationic Peptides.
Dailing E, Kilchrist K, Tierney J, Fletcher R, Evans B, Duvall C
ACS Appl Mater Interfaces. 2020; 12(45):50222-50235.
PMID: 33124813
PMC: 9082340.
DOI: 10.1021/acsami.0c13304.
Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor.
Gong Y, Klein Wolterink R, Janssen I, Groot A, Bos G, Germeraad W
Mol Ther Methods Clin Dev. 2020; 17:634-646.
PMID: 32300610
PMC: 7150439.
DOI: 10.1016/j.omtm.2020.03.017.
Curing Hemoglobinopathies: Challenges and Advances of Conventional and New Gene Therapy Approaches.
Motta I, Ghiaccio V, Cosentino A, Breda L
Mediterr J Hematol Infect Dis. 2019; 11(1):e2019067.
PMID: 31700592
PMC: 6827604.
DOI: 10.4084/MJHID.2019.067.